TY - JOUR
T1 - Evidence to suggest nitric oxide is an interstitial regulator of Leydig cell steroidogenesis
AU - Welch, Catherine
AU - Watson, Mary E.
AU - Poth, Merrily
AU - Hong, Timothy
AU - Francis, Gary L.
N1 - Funding Information:
From the Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC; the Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD; and The College of DuPage, Glen Ellyn, IL. Submitted December 29, 1993; accepted February 4, 1994. Supported by an intramural research grant from the Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the opinions of the Department of the Army or the Department of Defense. Address reprint requests to Gary L. Francis, MD, PhD, L TC, MC, USA, Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307-5001. Copyright © 1995 by W.B. Saunders Company 0026-0495/95/4402-0018503.00/0
PY - 1995/2
Y1 - 1995/2
N2 - Recent studies have suggested that nitric oxide (NO) may function as both an intracellular and intercellular signal that affects neural and immunological activity, vascular tone, platelet adhesion, and production of some hormones. Arginine analogs such as NG-monomethyl-l-arginine (l-NMMA) and Nω-nitro-l-arginine methyl ester (l-NAME) act to inhibit the intracellular formation of NO and have been used to study the effects of decreased NO formation on physiological systems. A single in vivo study has suggested that a similar analog, NG-nitro-l-arginine, increases serum testosterone (T), but the organ site and mechanism of action were not investigated. The present study was performed to investigate the effects of NO synthase inhibitors on Leydig cell function. l-NMMA and l-NAME, but not the inactive enantiomer (d-NMMA), increased both basal and human chorionic gonadotropin (hCG)-stimulated T production while decreasing guanosine 3′:5′-cyclic monophosphate (cGMP). There was no effect on either adenosine 3′:5′-cyclic monophosphate (cAMP) accumulation or specific hCG binding. These results suggest that NO formation, which is inhibited by l-NMMA and l-NAME, is important in the regulation of Leydig cell T production by interstitial cells of the testis, and that changes in cGMP levels might be involved in this process.
AB - Recent studies have suggested that nitric oxide (NO) may function as both an intracellular and intercellular signal that affects neural and immunological activity, vascular tone, platelet adhesion, and production of some hormones. Arginine analogs such as NG-monomethyl-l-arginine (l-NMMA) and Nω-nitro-l-arginine methyl ester (l-NAME) act to inhibit the intracellular formation of NO and have been used to study the effects of decreased NO formation on physiological systems. A single in vivo study has suggested that a similar analog, NG-nitro-l-arginine, increases serum testosterone (T), but the organ site and mechanism of action were not investigated. The present study was performed to investigate the effects of NO synthase inhibitors on Leydig cell function. l-NMMA and l-NAME, but not the inactive enantiomer (d-NMMA), increased both basal and human chorionic gonadotropin (hCG)-stimulated T production while decreasing guanosine 3′:5′-cyclic monophosphate (cGMP). There was no effect on either adenosine 3′:5′-cyclic monophosphate (cAMP) accumulation or specific hCG binding. These results suggest that NO formation, which is inhibited by l-NMMA and l-NAME, is important in the regulation of Leydig cell T production by interstitial cells of the testis, and that changes in cGMP levels might be involved in this process.
UR - http://www.scopus.com/inward/record.url?scp=0028928724&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028928724&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(95)90271-6
DO - 10.1016/0026-0495(95)90271-6
M3 - Article
C2 - 7869921
AN - SCOPUS:0028928724
SN - 0026-0495
VL - 44
SP - 234
EP - 238
JO - Metabolism
JF - Metabolism
IS - 2
ER -